Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v3-FR
Language French French
Date Updated 2017-07-21 2017-07-21
Drug Identification Number 02421364 02421364
Brand name RAN-MEMANTINE RAN-MEMANTINE
Common or Proper name RAN-MEMANTINE RAN-MEMANTINE
Company Name RANBAXY PHARMACEUTICALS CANADA INC. RANBAXY PHARMACEUTICALS CANADA INC.
Ingredients MEMANTINE HYDROCHLORIDE MEMANTINE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N06DX N06DX
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-07-12 2017-07-12
Actual discontinuation date 2017-07-12 2017-07-12
Remaining supply date 2017-07-12 2017-07-12
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments